Latest News

October 29, 2013 04:31 PM
ABC2 Collaboration Fuels New Pediatric Vaccine Trial at University of Florida

The Phase II trial is led by Dr. Duane Mitchell, director of the UF Brain Tumor Immunotherapy Program.

October 21, 2013 01:45 PM
Max Wallace Talks Innovation at Congress of Neurological Surgeons Annual Meeting

Key industry and foundation leaders were invited to share their disruptive ideas on the future of neurosurgery at the new CNS Neurosurgery Innovations Symposium.

October 15, 2013 04:37 PM
NCI/ABC2 Co-host Groundbreaking Clinical Trials Conference

A letter to the brain tumor community from Max Wallace, CEO of Accelerate Brain Cancer Cure.

October 14, 2013 12:50 PM
Breaking Through Cancer's Shield

The NCI/ABC2 meeting in September discussed how a powerful new class of immunotherapy drugs--PD-1 inhibitors--might be used to treat glioma. This New York Times article does a good job explaining the rationale behind the approach.

October 11, 2013 02:40 PM
The Cancer Genome Atlas exposes more secrets of lethal brain tumor

The Oct. 10 issue of Cell looks at the progress made by The Cancer Genome Atlas since its launch five years ago.

October 10, 2013 03:39 PM
Over the Edge for Brain Cancer Research - Media Advisory

Brain cancer survivors and VIPs to rappel down tallest building in San Diego on November 2 and 3 - all proceeds to benefit brain cancer research.

October 8, 2013 10:38 AM
Three Americans win Nobel Prize in medicine for work on traffic control system of cells

While the honorees expressed gratitude for the prize, their comments about their work were tinged with worry about the future of biomedical research after years of cuts in federal funding.

September 26, 2013 04:33 PM
Johns Hopkins Researchers Erase Human Brain Tumor Cells In Mice

The researchers caution that many treatments have cured cancers in mice and then failed in humans. But they are encouraged by the new findings and want to work quickly to design a clinical trial for humans.

September 17, 2013 01:30 PM
Brain Cancer Vaccine Gets Positive Phase 2 Results

Accelerate Brain Cancer Cure helped fund the Phase 2 trial led by Dr. Andrew Parsa, Chair of Neurosurgery at Northwestern Memorial Hospital.

August 23, 2013 12:51 PM
New Mayo Clinic Study: Avastin Boosts Survival in GBM

Researchers found that there was a “highly significant” increase in GBM patient survival in the year after Avastin was approved.

June 21, 2013 04:06 PM
Agios Files IPO To Advance Cancer Metabolism Research

Accelerate Brain Cancer Cure was an early investor in Agios to support its novel research into IDH1 gene mutation in brain cancer.   

June 18, 2013 12:08 PM
On Behalf of Patients, ABC2 Spurs Action On Avastin GBM Studies

A letter to the brain tumor community from Max Wallace, CEO of Accelerate Brain Cancer Cure.

June 13, 2013 12:18 PM
Max Wallace To Lead NCI Patient Advocate Group

This month, Max Wallace, CEO of Accelerate Brain Cancer Cure, was appointed chair of the National Cancer Institute Director's Consumer Liaison Group (DCLG). 

June 7, 2013 03:54 PM
Florida Reinstates Funding For Brain Tumor Research Center

Brain tumor research advocates, including Accelerate Brain Cancer Cure, were instrumental in the successful restoration of the program funding.

May 1, 2013 10:20 PM
Tocagen Continues To Make Progress On Its Innovative Brain Cancer Therapy

Accelerate Brain Cancer Cure was the first non-profit to fund Tocagen's virally-based drug delivery and treatment system for brain cancer.

April 15, 2013 10:39 AM
From Biotech Entrepreneur to Venture Philanthropy

Max Wallace, CEO of Accelerate Brain Cancer Cure, is a sought-after speaker at biotechnology conferences focusing on new approaches to funding treatments of the world’s most challenging diseases.

April 2, 2013 10:00 AM
White House Announces BRAIN Initiative

The BRAIN Initiative Challenges Researchers to Unlock Mysteries of Human Mind.

February 20, 2013 02:32 PM
Improving The Lives Of Those Affected By Brain Tumors

Ashley Varner guest blogs about her social work pilot study on the lived experience of family members who live with someone diagnosed with a primary malignant brain tumor.

February 1, 2013 06:12 PM
Low Grade Glioma Research Workshop

In partnership with UCSF and MD Anderson, ABC2 brought together researchers from leading medical centers and biotech companies to strategize new therapeutic paths to treat Low Grade Gliomas.

January 31, 2013 08:48 PM
ABC2-Funded Research Featured in Scientific American

The collaboration between academic and industry researchers aims to develop a test to detect genetic brain tumor mutations in cerebral spinal fluid and blood.   

January 29, 2013 06:41 PM
Into Fearless, Uncharted Territory: The Brain Cancer Expedition

Max Wallace, CEO of Accelerate Brain Cancer Cure, guest blogs for The Case Foundation about our new project that could revolutionize treatment for patients.

December 17, 2012 07:19 PM
Josh Sommer Named To Forbes' "30 Under 30" List

Josh Sommer is the founder of the Chordoma Foundation.  He is a good friend and we work closely with his organization on a variety of rare disease initiatives.

December 17, 2012 03:06 PM
A Tribute to Anne Feeley

Anne will always be remembered for her kind smile, wonderful sense of humor and determination to make this world a better place.

December 5, 2012 12:05 AM
Max Wallace To Speak At Dupont Summit

Max will join a panel of R&D experts to discuss "The Evolving Research Enterprise:  The Role of Foundations and Strategic Funding."

November 25, 2012 03:31 PM
Avastin Update - November, 2012

Max Wallace, CEO of Accelerate Brain Cancer Cure, provides perspective on the latest Avastin trial results by Genentech.

Pages

Share |

Join us in our fight for a cure!